Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Aura Biosciences, Inc. has filed 346 SEC EDGAR filings since 21 Sep 2010

SEC filing history

Showing 26-50 of 346 matching filings.

Per page
25
Current page
2
4

4

Filing date
03 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92997

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92997

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
20 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
20 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
17 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40971

144 filing

Filing date
29 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .